There were 1,031 press releases posted in the last 24 hours and 432,274 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Samsca (Tolvaptan): Drug Safety Communication - FDA Limits Duration and Usage Due To Possible Liver Injury Leading to Organ Transplant or Death

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image